InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Fundaro Paolo, Director. Director active across 1 company, notably Intercept Pharmaceuticals, INC.. Aggregated, 5 reports have been published. Activity tracked since 27 May 2021. The latest transaction was disclosed on 8 November 2023 (U). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Paolo Fundaro is a Board Member at INTERCEPT PHARMACEUTICALS, INC. He contributes to the governance of the company by bringing his expertise and participating in strategic decisions within the board of directors.